Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Yancey Gillespie

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Cancers|March 12, 2011
Cancer Stem Cells and Pediatric Solid TumorsGregory K Friedman, G Yancey Gillespie
Journal of Neuro-Oncology|July 25, 2006
Pharmacologic manipulations of mitochondrial membrane potential (DeltaPsim) selectively in glioma cellsCorinne E Griguer, Claudia R Oliva, G Yancey Gillespie, et al.
Journal of Neuro-Oncology|September 30, 2005
Glucose metabolism heterogeneity in human and mouse malignant glioma cell linesCorinne E Griguer, Claudia R Oliva, G Yancey Gillespie
Glia|October 6, 2005
Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinasesShao-Hua Chen, G Yancey Gillespie, Etty N Benveniste
Cells|October 31, 2020
Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic PotentialChristian T Stackhouse, G Yancey Gillespie, Christopher D Willey
Journal of Virology|January 5, 2002
Second-site mutation outside of the U(S)10-12 domain of Deltagamma(1)34.5 herpes simplex virus 1 recombinant blocks the shutoff of protein synthesis induced by activated protein kinase R and partially restores neurovirulenceKevin A Cassady, Martin Gross, G Yancey Gillespie, et al.
Journal of Neuro-Oncology|February 4, 2005
Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing miceSui Shen, M B Khazaeli, G Yancey Gillespie, et al.
Plos One|December 23, 2015
A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic AgentsG Clement Dobbins, Hideyo Ugai, David T Curiel, et al.
Journal of Neuro-Oncology|December 20, 2003
Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomasAmish C Shah, Dale Benos, G Yancey Gillespie, et al.
Oncotarget|March 2, 2015
Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomasClaudia R Oliva, Tahireh Markert, G Yancey Gillespie, et al.
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Cancers|March 12, 2011
Cancer Stem Cells and Pediatric Solid TumorsGregory K Friedman, G Yancey Gillespie
Journal of Neuro-Oncology|July 25, 2006
Pharmacologic manipulations of mitochondrial membrane potential (DeltaPsim) selectively in glioma cellsCorinne E Griguer, Claudia R Oliva, G Yancey Gillespie, et al.
Journal of Neuro-Oncology|September 30, 2005
Glucose metabolism heterogeneity in human and mouse malignant glioma cell linesCorinne E Griguer, Claudia R Oliva, G Yancey Gillespie
Glia|October 6, 2005
Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinasesShao-Hua Chen, G Yancey Gillespie, Etty N Benveniste
Cells|October 31, 2020
Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic PotentialChristian T Stackhouse, G Yancey Gillespie, Christopher D Willey
Journal of Virology|January 5, 2002
Second-site mutation outside of the U(S)10-12 domain of Deltagamma(1)34.5 herpes simplex virus 1 recombinant blocks the shutoff of protein synthesis induced by activated protein kinase R and partially restores neurovirulenceKevin A Cassady, Martin Gross, G Yancey Gillespie, et al.
Journal of Neuro-Oncology|February 4, 2005
Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing miceSui Shen, M B Khazaeli, G Yancey Gillespie, et al.
Plos One|December 23, 2015
A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic AgentsG Clement Dobbins, Hideyo Ugai, David T Curiel, et al.
Journal of Neuro-Oncology|December 20, 2003
Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomasAmish C Shah, Dale Benos, G Yancey Gillespie, et al.
Oncotarget|March 2, 2015
Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomasClaudia R Oliva, Tahireh Markert, G Yancey Gillespie, et al.
Pageof 13